Gut bugs may guide diabetes therapy, study finds
NCT ID NCT07627048
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how gut bacteria affect the development of type 2 diabetes and help personalize treatment. Researchers followed 100 adults newly diagnosed with type 2 diabetes who had not taken diabetes medication before. They analyzed stool samples and blood tests, then assigned different treatments to see how gut bacteria influenced treatment success.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
State clinical hospital named after V.P. Demikhov
Moscow, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection outperform semaglutide for diabetes remission?
- Can a drop of blood predict disease years before it strikes?
- Fatty liver may be a hidden driver of heart attacks in diabetes
- Could date seed powder help tame type 2 diabetes?
- Triple-Drug combo aims to improve diabetes control and weight loss
- Could a wearable sensor transform early diabetes care?